Cytotoxic T Cells-mediated Immune Response
Flow Cytometry
Antibody Structure
Frequency-dependent Selection
Contact-dependent Signaling
Receptor-mediated Endocytosis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 30, 2026

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
Irene van der Haar Àvila1,2, Patricia Marmol3, Jeannette Cany4
1Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. irevdhaarav@gmail.com.
Antibody-dependent cell-mediated cytotoxicity (ADCC) activates immune cells like natural killer (NK) cells to kill cancer cells. A flow cytometry assay uses trastuzumab to trigger ADCC against HER2-positive tumors.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: